Posts

BELLUSCURA’S CROWDFUNDING CAMPAIGN ON CROWDCUBE IS OVERFUNDED

LONDON, UK AND PLANO, TX  April 23, 2019.  Belluscura PLC is excited to announce that its crowdfunding campaign has exceeded the target raise of £500,000 ($647,000 USD). The campaign will remain open on Crowdcube (https://www.crowdcube.com) until May 3 to allow additional people the opportunity to invest in the company.

This raise will enable Belluscura to continue moving forward with regulatory clearance of its novel X-PLO2R™ portable oxygen concentrator for use in treating patients suffering from COPD. Belluscura anticipates launching the X-PLO2R in the fourth quarter of 2019.

Read more

Belluscura to present at UK Investor Show this Saturday

Visit Belluscura at Booth 65 at the UK Investor Show! See a live demonstration of the X-PLO2R portable oxygen concentrator, learn more about its unique technology and multiple advantages, and meet Belluscura’s CEO Bob Rauker and CFO Tony Dyer.

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.

Read more

Over 100 investors are now supporting Belluscura through crowdfunding!

To date, we have brought on more than 100 investors from 12 countries and we are very thankful for all the interest in, and support of the X-PLOR. Our goal is to help patients suffering from chronic lung diseases, such as COPD, to enjoy more active and fulfilling lifestyles. Please join us in helping millions of people in the world breathe easier – invest today!

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.

Read more

Visit Belluscura at Booth 65

 

Belluscura will be demonstrating the X-PLOR at the UK Investor Show on March 30. Come see us at Booth 65 for a hands-on experience with the world’s first modular portable oxygen concentrator.

Read more

Belluscura extends crowdfunding campaign

We are getting numerous inquiries about the X-PLO2R being presented at the UK Investor Show. Having received so much interest, we decided to extend our crowdfunding campaign until April 5. Come see us at the show March 30 and don’t miss out on this unique investment opportunity!

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.

See X-PLOR at the UK Investor Show

Belluscura will be presenting on March 30 at the UK Investor Show. Come experience in-person the X-PLO2R’s unique features and advantages, and meet Belluscura CEO Bob Rauker and CFO Tony Dyer.

Crowdfunding campaign reaches 48% of target in just two weeks!

After just two weeks of our @Crowdcube campaign, we are already at 48% of our funding target! We are excited to have brought on 73 investors from 9 countries. 16 days remaining in the campaign, so don’t miss out on this unique healthcare investment opportunity!

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.

David Poutney, CEO of Dowgate Capital, is supporting Belluscura’s Crowdfunding initiative

“Belluscura’s patented technology in the medical oxygen space has huge commercial potential whilst at the same time providing significant benefits to the lives of those suffering from COPD. I lost a dear friend to this debilitating disease and X-PLOR would have made a tremendous difference to quality of life in his final years. With other important applications in other fields such as wound care and portable artificial lungs, Belluscura can become a major player in the medical technology arena.”

Take advantage of this healthcare investment opportunity!    

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.

 

Second week of Crowdcube campaign

In just one week, our crowdfunding campaign @ Crowdcube brought on 51 investors from 6 countries. 23 days left in the campaign so be sure to take advantage of this healthcare investment opportunity!    

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.

Nigel Wray, serial investor, owner of Saracens Rugby Club and 25% shareholder, is supporting Belluscura’s Crowdfunding initiative

“I invest in many small companies and I am extremely excited about Belluscura’s X-PLOR oxygen concentrator, and the benefit it will have on COPD sufferers. That is why I am backing this business.”               

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.